Skip to main content

Table 1 Basic Characteristics of included patients

From: Clinical characteristics of inpatients with coronavirus disease 2019 (COVID-19) in Sichuan province

 

Diagnosis

Disease severity

Suspected

(n = 22)

Laboratory-confirmed

(n = 147)

Non-severe (n = 122)

Severe

(n = 25)

P value#

Age, median (IQR), yrs

51 (34–56)

44 (33–50)

43 (31–49)

50 (43–64)

0.005

Age groups, No./total (%)

 < 15 yrs

1/22 (4.6)

1/147 (0.7)

1/122 (0.8)

0/25 (0.0)

0.29*

 15–44 yrs

8/22 (36.4)

76/147 (51.7)

67/122 (54.9)

9/25 (36.0)

··

 45–64 yrs

10/22 (45.4)

54/147 (36·7)

42/122 (34·4)

12/25 (48·0)

··

 ≥ 65 yrs

3/22 (13·6)

16/147 (10·9)

12/122 (9·8)

4/25 (16·0)

··

Female sex, No./total (%)

7/22 (31·8)

57/147 (38·8)

51/122 (41·8)

6/25 (24·0)

0·096

Ethnic, No./total (%)

··

··

··

··

0·79

 Tibetan

0/22 (0·0)

10/147 (6·8)

8/122 (6·6)

2/25 (8·0)

··

 Non-Tibetan

22/22 (100·0)

137/147 (93·2)

114/122 (93·4)

23/25 (92·0)

··

Exposure history within 14 days, No./total (%)

 Local residents of Wuhan or recently been to Wuhan

4/13 (30·8)

82/134 (61·2)

66/110 (60·0)

16/24 (66·7)

0·54

 Non local: contacted with people from Wuhan

4/12 (33·3)

23/119 (19·3)

21/99 (21·2)

2/20 (10·0)

0·42

 Health-care workers

0/14 (0·0)

2/132 (1·5)

2/111 (1·8)

0/21 (0·0)

>  0·99*

Comorbidities, No./total (%)

6/21 (28·6)

47/146 (32·2)

32/122 (26·2)

15/24 (62·5)

0·0010

 Pulmonary diseases

2/21 (9·5)

11/146 (7·5)

5/122 (4·1)

6/24 (25)

0·0020

 Chronic obstructive pulmonary diseases

2/21 (9·5)

6/146 (4·1)

3/122 (2·5)

3/24 (12·5)

0·056*

 Asthma

1/21 (4·8)

1/146 (0·7)

0/122 (0·0)

1/24 (4·2)

0·16*

 Lung tumor

0/21 (0·0)

1/146 (0·7)

1/122 (0·8)

0/24 (0·0)

>  0·99*

 Tuberculosis

0/21 (0·0)

3/146 (2·1)

1/122 (0·8)

2/24 (8·3)

0·070*

 Other comorbidities

6/21 (28·6)

43/146 (29·5)

31/122 (25·4)

12/24 (50·0)

0·030

 Hypertension

3/21 (14·3)

19/146 (13·0)

11/122 (9·0)

8/24 (33·3)

0·0040

 Diabetes

2/21 (9·5)

10/146 (6·8)

6/122 (4·9)

4/24 (16·7)

0·10

 Heart and cardiovascular diseases

2/21 (9·5)

9/146 (6·2)

5/122 (4·1)

4/24 (16·7)

0·061

 Chronic kidney diseases

1/21 (4·8)

4/146 (2·7)

2/122 (1·6)

2/24 (8·3)

0·13*

 Chronic liver diseases

1/21 (4·8)

5/146 (3·4)

4/122 (3·3)

1/24 (4·2)

>  0·99*

  1. Abbreviations: IQR Interquartile range
  2. * The P-value was derived from Fisher’s exact test, two-sided
  3. # P-value for the comparison between severe cases versus non- severe infected patients